.

Spectrum Pharmaceuticals reported $-29032000 in Pre-Tax Profit for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Actinium Pharmaceuticals ATNM:US $ -7767000 2.64M
Agios Pharmaceuticals AGIO:US $ -91.81M 2.97M
Alnylam Pharmaceuticals ALNY:US $ -274.67M 35.32M
Arrowhead Research ARWR:US $ -72.05M 116.41M
Astellas Pharma 4503:JP Y 31679M 42195M
AstraZeneca AZN:LN 258259.83M 36783.7M
Biogen BIIB:US $ 874.8M 28.6M
Coherus Biosciences CHRS:US $ -50.15M 45.93M
Intercept Pharmaceuticals ICPT:US $ -20.32M 3.04M
Karyopharm Therapeutics KPTI:US $ -48941000 7.67M
Mirati Therapeutics MRTX:US $ -176.44M 11.94M
Novartis NOVN:VX SF 4129M 217M
Sanofi SAN:FP € 2660M 305M
Spectrum Pharmaceuticals SPPI:US $ -29.03M 13.65M
Takeda 4502:JP Y 155473M 209520M
Teva Pharmaceutical TEVA:IT -1160000000 189M
Tg Therapeutics TGTX:US $ -40.51M 28.5M